Back to search

Article

Urinary Metabolites and Survival in Malignant Mesothelioma

2025-09-25

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Malignant mesothelioma is a rare and aggressive malignancy with limited treatment options and poor survival outcomes. Current biomarkers such as MESOMARK, fibulin-3, and osteopontin show diagnostic potential but remain hampered by inconsistent sensitivity and reproducibility. Urine-based metabolites may provide a simple, noninvasive alternative for prognosis and disease moni...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
765bf741-6c5f-532e-8882-10690d3bab18
DOI
10.1101/2025.09.23.25336488
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Urinary Metabolites and Survival in Malignant MesotheliomaDOI 10.1101/2025.09.23.25336488
Select a neighboring publication to make it the new centre.